Medicare Compliance & Reimbursement

Reimbursement:

GAO TARGETS NEW AWP PAYMENT HEMORRHAGE

As with most covered drugs and biologicals,Medicare pays way too much for blood clotting factor, the General Accounting Office maintains in a report released Feb. 12. The culprit is familiar: Payment for blood clotting factor — a biological used by hemophiliacs to prevent uncontrolled internal bleeding — is based on the now-notorious “average wholesale price,” a manufacturer-set price some critics [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All